Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $87.44 million. The enterprise value is $97.41 million.

Market Cap	87.44M
Enterprise Value	97.41M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CLSD has 74.73 million shares outstanding. The number of shares has increased by 14.20% in one year.

Shares Outstanding	74.73M
Shares Change (YoY)	+14.20%
Shares Change (QoQ)	+11.92%
Owned by Insiders (%)	7.43%
Owned by Institutions (%)	28.97%
Float	65.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.34
Forward PS	172.48
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	11.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.07

Current Ratio	6.07
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-94.70%
Return on Capital (ROIC)	-114.57%
Revenue Per Employee	$281,733
Profits Per Employee	-$1.17M
Employee Count	30
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.65% in the last 52 weeks. The beta is 2.44, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	2.44
52-Week Price Change	-5.65%
50-Day Moving Average	1.26
200-Day Moving Average	1.23
Relative Strength Index (RSI)	43.40
Average Volume (20 Days)	173,753

Short Selling Information

The latest short interest is 226,918, so 0.30% of the outstanding shares have been sold short.

Short Interest	226,918
Short Previous Month	193,046
Short % of Shares Out	0.30%
Short % of Float	0.35%
Short Ratio (days to cover)	1.23

Income Statement

In the last 12 months, CLSD had revenue of $8.45 million and -$34.97 million in losses. Loss per share was -$0.55.

Revenue	8.45M
Gross Profit	8.10M
Operating Income	-26.95M
Pretax Income	-34.97M
Net Income	-34.97M
EBITDA	-34.89M
EBIT	-34.97M
Loss Per Share	-$0.55

Full Income Statement

Balance Sheet

The company has $35.36 million in cash and $45.33 million in debt, giving a net cash position of -$9.98 million or -$0.13 per share.

Cash & Cash Equivalents	35.36M
Total Debt	45.33M
Net Cash	-9.98M
Net Cash Per Share	-$0.13
Equity (Book Value)	-21.81M
Book Value Per Share	-0.29
Working Capital	30.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.77 million and capital expenditures -$1.72 million, giving a free cash flow of -$20.49 million.

Operating Cash Flow	-18.77M
Capital Expenditures	-1.72M
Free Cash Flow	-20.49M
FCF Per Share	-$0.29

Full Cash Flow Statement

Margins

Gross margin is 95.80%, with operating and profit margins of -318.82% and -413.72%.

Gross Margin	95.80%
Operating Margin	-318.82%
Pretax Margin	-413.72%
Profit Margin	-413.72%
EBITDA Margin	-412.78%
EBIT Margin	-413.72%
FCF Margin	-242.42%

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.20%
Shareholder Yield	-14.20%
Earnings Yield	-39.99%
FCF Yield	-23.43%

Analyst Forecast

The average price target for CLSD is $4.60, which is 293.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.60
Price Target Difference	293.16%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	77.65%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CLSD has an Altman Z-Score of -12.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.52
Piotroski F-Score	3